Kerendia (finerenone)

pCPA File Number: 22323

Negotiation Status:

Concluded with an LOI

Indication(s):

Adjunct to standard of care therapy for chronic kidney disease and type 2 diabetes

Sponsor/Manufacturer:

Bayer Inc.

CDA-AMC Project Number:

SR0737-000

pCPA Engagement Letter Issued:

2023-08-15

Negotiation Process Concluded:

2023-11-16